Pandemic risk characterisation of zoonotic influenza A viruses using the Tool for Influenza Pandemic Risk Assessment (TIPRA).


Journal

The Lancet. Microbe
ISSN: 2666-5247
Titre abrégé: Lancet Microbe
Pays: England
ID NLM: 101769019

Informations de publication

Date de publication:
10 Oct 2024
Historique:
received: 28 06 2024
revised: 26 07 2024
accepted: 09 08 2024
medline: 14 10 2024
pubmed: 14 10 2024
entrez: 13 10 2024
Statut: aheadofprint

Résumé

A systematic risk assessment approach is essential for evaluating the relative risk of influenza A viruses (IAVs) with pandemic potential. To achieve this, the Tool for Influenza Pandemic Risk Assessment (TIPRA) was developed under the Global Influenza Programme of WHO. Since its release in 2016 and update in 2020, TIPRA has been used to assess the pandemic risk of 11 zoonotic IAVs across ten evaluation rounds. Notably, A(H7N9), A(H9N2), and A(H5) clade 2.3.4.4 viruses were re-evaluated owing to changes in epidemiological characteristics or virus properties. A(H7N9) viruses had the highest relative risk at the time of assessment, highlighting the importance of continuous monitoring and reassessment as changes in epidemiological trends within animal and human populations can alter risk profiles. The knowledge gaps identified throughout the ten risk assessments should help to guide the efficient use of resources for future research, including surveillance. The TIPRA tool reflects the One Health approach and has proven crucial for closely monitoring virus dynamics in both human and non-human populations to enhance preparedness for potential IAV pandemics.

Identifiants

pubmed: 39396528
pii: S2666-5247(24)00234-9
doi: 10.1016/j.lanmic.2024.100973
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

100973

Informations de copyright

Copyright © 2024 World Health Organization. Published by Elsevier Ltd.. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests GN is a Co-Founder of FluGen. All other authors declare no competing interests.

Auteurs

Reina Yamaji (R)

Global Influenza Programme, Epidemic and Pandemic Preparedness and Prevention, WHO Emergency Programme, World Health Organization, Geneva, Switzerland.

Wenqing Zhang (W)

Global Influenza Programme, Epidemic and Pandemic Preparedness and Prevention, WHO Emergency Programme, World Health Organization, Geneva, Switzerland.

Akiko Kamata (A)

The Food and Agriculture Organization of the UN (FAO), Rome, Italy.

Cornelia Adlhoch (C)

European Centre for Disease Prevention and Control, Solna, Sweden.

David E Swayne (DE)

Birdflu Veterinarian, Watkinsville, GA, USA.

Dmitriy Pereyaslov (D)

Global Influenza Programme, Epidemic and Pandemic Preparedness and Prevention, WHO Emergency Programme, World Health Organization, Geneva, Switzerland.

Dayan Wang (D)

National Institute for Viral Disease Control and Prevention, China CDC, Changping District, Beijing, China.

Gabriele Neumann (G)

Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, WI, USA.

Gounalan Pavade (G)

World Organisation for Animal Health, Paris, France.

Ian G Barr (IG)

WHO Collaborating Centre for Reference and Research on Influenza, Victorian Infectious Diseases Reference Laboratory, Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia.

Malik Peiris (M)

School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China.

Richard J Webby (RJ)

Department of Infectious Diseases, St Jude Children's Research Hospital, Memphis, TN, USA.

Ron A M Fouchier (RAM)

Department of Viroscience, Erasmus Medical Centre, Rotterdam, Netherlands.

Sophie Von Dobschütz (S)

The Food and Agriculture Organization of the UN (FAO), Rome, Italy; Emerging Diseases and Zoonoses Unit, Department for Epidemic and Pandemic Preparedness and Prevention, World Health Organization, Geneva, Switzerland.

Thomas Fabrizio (T)

Department of Infectious Diseases, St Jude Children's Research Hospital, Memphis, TN, USA.

Yuelong Shu (Y)

Institute of Pathogen Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.

Magdi Samaan (M)

Global Influenza Programme, Epidemic and Pandemic Preparedness and Prevention, WHO Emergency Programme, World Health Organization, Geneva, Switzerland. Electronic address: saadsamaanm@who.int.

Classifications MeSH